STAT1 and breast carcinoma: 33). In the breast cancer context, on the other hand, it has been observed that PARP12 is an active contributor of IFN/STAT1 signalling pathway involved in post-chemotherapy survival and re-growth of breast cancer cells (Ref. 34).